Skip to search.
 TSX Up 0.40% TSX Ventures Up 0.08%

Athersys, Inc. (ATHX)

-NasdaqCM
2.13 Down 0.02(0.93%) 2:01PM EDT - Nasdaq Real Time Price
Prev Close:2.15
Open:2.16
Bid:2.11 x 6000
Ask:2.12 x 400
1y Target Est:7.00
Beta:-0.989144
Next Earnings Date: 9-Aug-16ATHX Earnings announcement
Day's Range:2.11 - 2.16
52wk Range:0.94 - 2.90
Volume:182,596
Avg Vol (3m):559,075
Market Cap:179.70M
P/E (ttm):213.00
EPS (ttm):0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ATHXDown 0.93%179.70M
OSIRDown 2.00%169.16M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.23
Quarterly EPS Est (Jun-16) :-0.10
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback